Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Early Diagnosis in Pulmonary Arterial Hypertension, the Search for the Holy Grail.

Berger RMF, Beghetti M.

Am J Respir Crit Care Med. 2019 Jan 16. doi: 10.1164/rccm.201812-2314ED. [Epub ahead of print] No abstract available.

PMID:
30649901
2.

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.

Beghetti M, Channick RN, Chin KM, Di Scala L, Gaine S, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Galiè N.

Eur J Heart Fail. 2019 Jan 11. doi: 10.1002/ejhf.1375. [Epub ahead of print]

PMID:
30632656
3.

Congenital Portosystemic Shunts: Current Diagnosis and Management.

McLin VA, Franchi-Abella S, Debray D, Guérin F, Beghetti M, Savale L, Wildhaber BE, Gonzales E; Members of the International Registry of Congenital Porto-Systemic Shunts.

J Pediatr Gastroenterol Nutr. 2019 Jan 4. doi: 10.1097/MPG.0000000000002263. [Epub ahead of print]

PMID:
30628988
4.

An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence.

Wacker J, Weintraub R, Beghetti M.

Expert Rev Respir Med. 2019 Jan 5. doi: 10.1080/17476348.2019.1565998. [Epub ahead of print]

PMID:
30614292
5.

Evaluation of Macitentan in Patients With Eisenmenger Syndrome.

Gatzoulis MA, Landzberg M, Beghetti M, Berger RM, Efficace M, Gesang S, He J, Papadakis K, Pulido T, Galiè N; MAESTRO Study Investigators.

Circulation. 2019 Jan 2;139(1):51-63. doi: 10.1161/CIRCULATIONAHA.118.033575.

PMID:
30586694
6.

Regression of Advanced Liver Fibrosis After Heart Transplantation in a Patient With Prior Fontan Surgery for Complex Congenital Heart Disease.

Bouchardy J, Meyer P, Yerly P, Blanche C, Hullin R, Giostra E, Hanquinet S, Rubbia-Brandt L, Sekarski N, Prêtre R, Beghetti M.

Circ Heart Fail. 2018 Nov;11(11):e003754. doi: 10.1161/CIRCHEARTFAILURE.117.003754. No abstract available.

PMID:
30571198
7.

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.

Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, Ivy DD, Berger RMF.

Eur Respir J. 2018 Dec 13. pii: 1801916. doi: 10.1183/13993003.01916-2018. [Epub ahead of print]

8.

Rotation of the outflow tracts for complex transposition of the great arteries.

Myers PO, Sologashvili T, Beghetti M, Prêtre R.

Multimed Man Cardiothorac Surg. 2018 Jul 3;2018. doi: 10.1510/mmcts.2018.036.

9.

Serum cardiovascular risk biomarkers in pre-pubertal obese children.

Maggio ABR, Farpour-Lambert NJ, Aggoun Y, Galan K, Montecucco F, Mach F, Beghetti M.

Eur J Clin Invest. 2018 Sep;48(9):e12995. doi: 10.1111/eci.12995. Epub 2018 Aug 6.

PMID:
29992540
10.

Definition and Management of Segmental Pulmonary Hypertension.

Dimopoulos K, Diller GP, Opotowsky AR, D'Alto M, Gu H, Giannakoulas G, Budts W, Broberg CS, Veldtman G, Swan L, Beghetti M, Gatzoulis MA.

J Am Heart Assoc. 2018 Jul 4;7(14). pii: e008587. doi: 10.1161/JAHA.118.008587. No abstract available.

11.

Two-stage arterial switch for late-presenting transposition of the great arteries.

Sologashvili T, Wannaz L, Beghetti M, Aggoun Y, Prêtre R, Myers PO.

Interact Cardiovasc Thorac Surg. 2018 Oct 1;27(4):581-585. doi: 10.1093/icvts/ivy093.

PMID:
29912349
12.

Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.

Blanche C, Alonso-Gonzalez R, Uribarri A, Kempny A, Swan L, Price L, Wort SJ, Beghetti M, Dimopoulos K.

Int J Cardiol. 2018 Sep 15;267:79-83. doi: 10.1016/j.ijcard.2018.05.062. Epub 2018 May 19.

PMID:
29807779
13.

Rotation of the outflow tracts.

Sologashvili T, Myers PO, Beghetti M, Prêtre R.

Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):463-464. doi: 10.1093/icvts/ivy087.

PMID:
29590369
14.

Modern Invasive Hemodynamic Assessment of Pulmonary Hypertension.

Pagnamenta A, Lador F, Azzola A, Beghetti M.

Respiration. 2018;95(3):201-211. doi: 10.1159/000484942. Epub 2018 Jan 9. Review.

PMID:
29316567
15.
16.

Invasive haemodynamic evaluation of the pulmonary circulation in pulmonary hypertension.

Pagnamenta A, Azzola A, Beghetti M, Lador F, On Behalf Of The Swiss Society Of Pulmonary Hypertension.

Swiss Med Wkly. 2017 Jul 13;147:w14445. doi: 10.4414/smw.2017.14445. eCollection 2017. Review.

17.

[Pectus excavatumn and carinatum in children and adolescents : what to say, what to do ?]

Lascombes P, Ruchonnet-Métrailler I, Beghetti M, Bottani A, Wilde J.

Rev Med Suisse. 2017 Feb 15;13(550):414-420. French.

PMID:
28714634
18.

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.

Beghetti M, Rudzinski A, Zhang M.

BMC Cardiovasc Disord. 2017 Jul 4;17(1):177. doi: 10.1186/s12872-017-0569-3.

19.

Adapting the "Chester step test" to predict peak oxygen uptake in children.

Maggio ABR, Vuistiner P, Crettenand A, Tabin R, Martin XE, Beghetti M, Farpour-Lambert NJ, Deriaz O.

Swiss Med Wkly. 2017 May 10;147:w14435. doi: 10.4414/smw.2017.14435. eCollection 2017.

20.

Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.

Zhang HD, Lv ZC, Wang LT, Rothman A, Lian TY, He YY, Wu Y, Lawrie A, Beghetti M, Jing ZC.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1478-1481. doi: 10.1164/rccm.201701-0131LE. No abstract available.

21.

A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3.

Berger RMF, Gehin M, Beghetti M, Ivy D, Kusic-Pajic A, Cornelisse P, Grill S, Bonnet D; FUTURE-3 investigators.

Br J Clin Pharmacol. 2017 Aug;83(8):1734-1744. doi: 10.1111/bcp.13267. Epub 2017 Mar 23.

22.

Yasui procedure.

Myers PO, Sologashvili T, Wacker J, Vallée JP, Beghetti M, Prêtre R.

Multimed Man Cardiothorac Surg. 2016 Dec 9;2016. doi: 10.1510/mmcts.2016.005.

23.

Pediatric Development of Bosentan Facilitated by Modeling and Simulation.

Zisowsky J, Géhin M, Kusic-Pajic A, Krause A, Beghetti M, Dingemanse J.

Paediatr Drugs. 2017 Apr;19(2):121-130. doi: 10.1007/s40272-016-0206-0.

PMID:
28078552
24.

Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.

Humpl T, Berger RMF, Austin ED, Fasnacht Boillat MS, Bonnet D, Ivy DD, Zuk M, Beghetti M, Schulze-Neick I.

Cardiol Young. 2017 Aug;27(6):1123-1132. doi: 10.1017/S1047951116002493. Epub 2016 Dec 20.

PMID:
27995825
25.

Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension.

Lador F, Bringard A, Bengueddache S, Ferretti G, Bendjelid K, Soccal PM, Noble S, Beghetti M, Chemla D, Hervé P, Sitbon O.

Biomed Res Int. 2016;2016:6050193. Epub 2016 Nov 20.

26.

Successful Lung Transplant After Prolonged Extracorporeal Membrane Oxygenation (ECMO) in a Child With Pulmonary Hypertension: A Case Report.

Tissot C, Habre W, Soccal P, Hug MI, Bettex D, Pellegrini M, Aggoun Y, Mornand A, Kalangos A, Rimensberger P, Beghetti M.

Res Cardiovasc Med. 2016 Jul 16;5(3):e32545. eCollection 2016 Aug.

27.
28.

Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].

Berger RM, Haworth SG, Bonnet D, Dulac Y, Fraisse A, Galiè N, Ivy DD, Jaïs X, Miera O, Rosenzweig EB, Efficace M, Kusic-Pajic A, Beghetti M.

Int J Cardiol. 2016 Nov 15;223:1072-1073. doi: 10.1016/j.ijcard.2016.08.333. Epub 2016 Aug 24. No abstract available.

PMID:
27623401
29.

Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial.

Steinhorn RH, Fineman J, Kusic-Pajic A, Cornelisse P, Gehin M, Nowbakht P, Pierce CM, Beghetti M; FUTURE-4 study investigators.

J Pediatr. 2016 Oct;177:90-96.e3. doi: 10.1016/j.jpeds.2016.06.078. Epub 2016 Aug 5.

PMID:
27502103
30.

Dual-energy computed tomographic imaging of pulmonary hypertension.

Hachulla AL, Lador F, Soccal PM, Montet X, Beghetti M.

Swiss Med Wkly. 2016 Aug 6;146:w14328. doi: 10.4414/smw.2016.14328. eCollection 2016. Review.

31.

Surgical Repair of Mitral Valve Disease in Children: Perioperative Changes in Respiratory Function.

Malaspinas I, Petak F, Chok L, Perrin A, Martin AL, Beghetti M, Habre W.

J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1286-95. doi: 10.1053/j.jvca.2016.05.018. Epub 2016 May 17.

PMID:
27495965
32.

Norwood Stage 1 With Surgical Ventricular Reconstruction and Mitral Valve Repair for Neonatal Idiopathic Left Ventricular Dilated Cardiomyopathy.

Myers PO, Sologashvili T, Beghetti M, Tissot C.

Ann Thorac Surg. 2016 Jul;102(1):e15-7. doi: 10.1016/j.athoracsur.2015.11.005.

PMID:
27343520
33.

eComment: How to define operability in pulmonary hypertension secondary to congenital heart disease?

Myers PO, Lador F, Beghetti M.

Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):859. doi: 10.1093/icvts/ivw131. No abstract available.

34.

Unrestrictive Aortopulmonary Window: Extreme Presentation as Non-Eisenmenger in a 30-Year-Old Patient.

Myers PO, Lador F, Hachulla AL, Bouchardy J, Noble S, Licker M, Pache JC, Kalimanovaska-Ostric D, Djukic M, Kalangos A, Beghetti M.

Circulation. 2016 May 10;133(19):1907-10. doi: 10.1161/CIRCULATIONAHA.115.020819. No abstract available.

PMID:
27166350
35.

Pulmonary hypertension in the elderly: a different disease?

Berra G, Noble S, Soccal PM, Beghetti M, Lador F.

Breathe (Sheff). 2016 Mar;12(1):43-9. doi: 10.1183/20734735.003416. Review.

36.

BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease.

Liu D, Liu QQ, Guan LH, Jiang X, Zhou DX, Beghetti M, Qu JM, Jing ZC.

Int J Cardiol. 2016 May 15;211:132-6. doi: 10.1016/j.ijcard.2016.02.150. Epub 2016 Mar 7.

PMID:
27002414
37.

Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study.

Ploegstra MJ, Ivy DD, Wheeler JG, Brand M, Beghetti M, Rosenzweig EB, Humpl T, Iriart X, Rouzic EM, Bonnet D, Berger RM.

Lancet Respir Med. 2016 Apr;4(4):281-90. doi: 10.1016/S2213-2600(16)00069-2. Epub 2016 Mar 16.

PMID:
26994897
38.

Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.

Douwes JM, Humpl T, Bonnet D, Beghetti M, Ivy DD, Berger RM; TOPP Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1312-23. doi: 10.1016/j.jacc.2016.01.015.

39.

To "Cath" or Not in Pediatric Pulmonary Hypertension?

Beghetti M, Berger RM, Ivy DD, Bonnet D, Humpl T.

J Am Coll Cardiol. 2016 Mar 1;67(8):1010-1. doi: 10.1016/j.jacc.2015.11.056. No abstract available.

40.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
41.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

42.

Editorial: Pediatric Pulmonary Hypertension.

Beghetti M, Lador F.

Front Pediatr. 2015 Nov 30;3:105. doi: 10.3389/fped.2015.00105. eCollection 2015. No abstract available.

43.

Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).

Beghetti M, Schulze-Neick I, Berger RM, Ivy DD, Bonnet D, Weintraub RG, Saji T, Yung D, Mallory GB, Geiger R, Berger JT, Barst RJ, Humpl T; TOPP Investigators.

Int J Cardiol. 2016 Jan 15;203:325-30. doi: 10.1016/j.ijcard.2015.10.087. Epub 2015 Oct 23.

PMID:
26583838
44.

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.

Berger RM, Haworth SG, Bonnet D, Dulac Y, Fraisse A, Galiè N, Ivy DD, Jaïs X, Miera O, Rosenzweig EB, Efficace M, Kusic-Pajic A, Beghetti M.

Int J Cardiol. 2016 Jan 1;202:52-8. doi: 10.1016/j.ijcard.2015.08.080. Epub 2015 Aug 9. Erratum in: Int J Cardiol. 2016 Nov 15;223:1072-1073.

PMID:
26386921
45.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

46.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

47.

Riociguat for pulmonary arterial hypertension associated with congenital heart disease.

Rosenkranz S, Ghofrani HA, Beghetti M, Ivy D, Frey R, Fritsch A, Weimann G, Saleh S, Apitz C.

Heart. 2015 Nov;101(22):1792-9. doi: 10.1136/heartjnl-2015-307832. Epub 2015 Jul 1.

48.

Asymptomatic right circumflex aortic arch associated with ventricular septal defect and biscuspid aortic valve.

Tissot C, Didier D, Beghetti M, Kalangos A, Myers PO.

Heart Surg Forum. 2015 Jun 26;18(3):E114-5. doi: 10.1532/hsf.1313.

PMID:
26115157
49.

[Congenital heart disease: from childhood to adulthood].

Sekarski N, Bouchardy J, Rutz T, Di Bernardo S, Mivelaz Y, Boulos Ksontini T, Aggoun Y, Tissot C, Geiser V, Gendre C, Beghetti M.

Rev Med Suisse. 2015 Feb 18;11(462):438, 440-4. French.

PMID:
25915984
50.

Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature.

L'Huillier AG, Posfay-Barbe KM, Pictet H, Beghetti M.

Front Pediatr. 2015 Apr 7;3:25. doi: 10.3389/fped.2015.00025. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center